February 21, 2018
Biogen CEO Michel Vounatsos in Tokyo Interview Biogen CEO Michel Vounatsos on February 20 shrugged off concerns surrounding a change announced last week for the big biotech’s key Alzheimer’s trial for aducanumab, saying that enlarging the patient enrollment is a...read more